BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23884271)

  • 1. Thionamide-induced neutropenia and ecthyma in a pregnant patient with hyperthyroidism.
    Thomas SK; Sheffield JS; Roberts SW
    Obstet Gynecol; 2013 Aug; 122(2 Pt 2):490-492. PubMed ID: 23884271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk for thionamide-induced agranulocytosis in elderly patients: a case presentation and literature review.
    Bukhari S; Khan M; Kumar N; Mohan V
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28716776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propylthiouracil-induced agranulocytosis in the third trimester of pregnancy.
    Murji A; Sobel ML; Feig DS; Sermer M
    Obstet Gynecol; 2010 Aug; 116 Suppl 2():485-487. PubMed ID: 20664427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of a pregnant patient with Graves' disease complicated by thionamide-induced neutropenia in the first trimester.
    Davison S; Lennard TW; Davison J; Kendall-Taylor P; Perros P
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):559-61. PubMed ID: 11318795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy.
    Finucane FM; O'Connell J; Kinsley BT
    Ir J Med Sci; 2008 Mar; 177(1):69-71. PubMed ID: 17611791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rare side effects in management of hyperthyroidism. Case report].
    Sohár G; Kovács M; Györkös A; Gasztonyi B
    Orv Hetil; 2016 May; 157(22):869-72. PubMed ID: 27211356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of antithyroid drugs in pregnancy: update and therapy implications.
    Francis T; Francis N; Lazarus JH; Okosieme OE
    Expert Opin Drug Saf; 2020 May; 19(5):565-576. PubMed ID: 32223355
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of a pregnant patient with Graves' disease complicated by propylthiouracil induced agranulocytosis.
    Cho YY; Shon HS; Yoon HD
    Korean J Intern Med; 2005 Dec; 20(4):335-8. PubMed ID: 16491833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis.
    Li X; Liu GY; Ma JL; Zhou L
    Clinics (Sao Paulo); 2015 Jun; 70(6):453-9. PubMed ID: 26106966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutropenic colitis with cecal perforation during antithyroid therapy.
    Chen DF; Chao IM; Huang SH
    J Formos Med Assoc; 2003 Sep; 102(9):644-6. PubMed ID: 14625610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thionamide-induced Agranulocytosis: A Retrospective Analysis of 36 Patients With Hyperthyroidism.
    Zhu D; Zhang S; Cao X; Xia Q; Zhang Q; Deng D; Gao S; Yu H; Liu Y; Zhou H; Tao F; Sun X
    Endocr Pract; 2021 Dec; 27(12):1183-1188. PubMed ID: 34216800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization to Methimazole.
    Mazhari A; Emanuele MA; Espiritu B
    Endocr Pract; 2021 Mar; 27(3):185-190. PubMed ID: 33779553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithyroid drugs.
    Cooper DS
    N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period.
    Sarkar S; Bischoff LA
    Semin Reprod Med; 2016 Nov; 34(6):317-322. PubMed ID: 27741549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepsis mimicking thyroid storm in a patient with methimazole-induced agranulocytosis.
    Rayner SG; Hosseini F; Adedipe AA
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23861276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of hypo- and hyperthyroidism in pregnancy].
    Lind P
    Acta Med Austriaca; 1997; 24(4):157-8. PubMed ID: 9441554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of Shift in Antithyroid Drug Therapy and Birth Defects.
    Andersen SL; Andersen S
    Thyroid; 2019 Jan; 29(1):155-156. PubMed ID: 30458113
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis.
    Liu Y; Li Q; Xu Y; Chen Y; Men Y
    PLoS One; 2023; 18(5):e0286097. PubMed ID: 37205692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
    Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ
    Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propylthiouracil versus methimazole during pregnancy: an evolving tale of difficult choices.
    Rivkees SA
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4332-5. PubMed ID: 24194618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.